{"id":"https://openalex.org/W3000659570","doi":"https://doi.org/10.1111/bcp.14210","title":"Naltrexone\u2013bupropion (Mysimba) in management of obesity: A systematic review and meta\u2010analysis of unpublished clinical study reports","display_name":"Naltrexone\u2013bupropion (Mysimba) in management of obesity: A systematic review and meta\u2010analysis of unpublished clinical study reports","alternate_titles":[],"publication_year":2020,"publication_date":"2020-02-04","ids":{"openalex":"https://openalex.org/W3000659570","doi":"https://doi.org/10.1111/bcp.14210","mag":"3000659570","pmid":"https://pubmed.ncbi.nlm.nih.gov/31918448","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7098870"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.14210","doi":"https://doi.org/10.1111/bcp.14210","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.14210","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3000659570"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7098870/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062680588","display_name":"Igho Onakpoya","orcid":"https://orcid.org/0000-0002-2420-0811","observed_orcids":["https://orcid.org/0000-0002-2420-0811"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Igho J. Onakpoya","raw_affiliation_strings":["Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0002-2420-0811","affiliations":[{"raw_affiliation_string":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100362487","display_name":"Joseph Jonathan Lee","orcid":"https://orcid.org/0000-0002-4033-0915","observed_orcids":["https://orcid.org/0000-0002-4033-0915"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph J. Lee","raw_affiliation_strings":["Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031091511","display_name":"Kamal  Ram Mahtani","orcid":"https://orcid.org/0000-0002-7791-8552","observed_orcids":["https://orcid.org/0000-0002-7791-8552"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kamal R. Mahtani","raw_affiliation_strings":["Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081151451","display_name":"Jeffrey K Aronson","orcid":"https://orcid.org/0000-0003-1139-655X","observed_orcids":["https://orcid.org/0000-0003-1139-655X"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey K. Aronson","raw_affiliation_strings":["Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0003-1139-655X","affiliations":[{"raw_affiliation_string":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027878704","display_name":"Carl J. Heneghan","orcid":"https://orcid.org/0000-0002-1009-1992","observed_orcids":["https://orcid.org/0000-0002-1009-1992"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carl J. Heneghan","raw_affiliation_strings":["Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062680588"],"corresponding_institution_ids":["https://openalex.org/I40120149"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.9798,"has_fulltext":true,"cited_by_count":93,"citation_normalized_percentile":{"value":0.6662234,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"86","issue":"4","first_page":"646","last_page":"667"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10569","display_name":"Bariatric Surgery and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10010","display_name":"Obesity, Physical Activity, Diet","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naltrexone-bupropion","display_name":"naltrexone/bupropion","score":0.996999979019165},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.6600000262260437},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.875},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.8989999890327454},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.6669999957084656},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.5360000133514404},{"id":"https://openalex.org/keywords/obesity-pharmacotherapy","display_name":"obesity pharmacotherapy","score":0.5049999952316284},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.3149999976158142},{"id":"https://openalex.org/keywords/regulatory-decision-making","display_name":"regulatory decision-making","score":0.43700000643730164},{"id":"https://openalex.org/keywords/european-medicines-agency","display_name":"European Medicines Agency","score":0.5870000123977661},{"id":"https://openalex.org/keywords/food-and-drug-administration","display_name":"Food and Drug Administration","score":0.9010000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7965318560600281},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6523995399475098},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.649042010307312},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6363179683685303},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.622261643409729},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.5901126861572266},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.5885462164878845},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.5836865901947021},{"id":"https://openalex.org/C67774102","wikidata":"https://www.wikidata.org/wiki/Q614132","display_name":"Number needed to treat","level":4,"score":0.5495166778564453},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5225828886032104},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.44411197304725647},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.43958595395088196},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4250040650367737},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41059887409210205},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.1603078544139862},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.1149311363697052},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.09464621543884277},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/bcp.14210","doi":"https://doi.org/10.1111/bcp.14210","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.14210","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7098870","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7098870/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:31918448","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31918448","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:ora.ox.ac.uk:uuid:269e86c6-b1cf-400e-914e-35f6f1cc8fc3","doi":null,"is_oa":true,"landing_page_url":"https://ora.ox.ac.uk/objects/uuid:269e86c6-b1cf-400e-914e-35f6f1cc8fc3","pdf_url":"https://ora.ox.ac.uk/objects/uuid:269e86c6-b1cf-400e-914e-35f6f1cc8fc3/files/mb10a5a357481998cd141c4262b06adf7","source":{"id":"https://openalex.org/S4306402636","display_name":"Oxford University Research Archive (ORA) (University of Oxford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40120149","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/I40120149"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Symplectic Elements at Oxford","raw_type":"Journal article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7098870","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7098870/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[{"id":"https://openalex.org/G212743063","display_name":"In-Practice Fellowship 2017","funder_award_id":"IPF-2017-11-020","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320290","display_name":"University of Oxford","ror":"https://ror.org/052gg0110"},{"id":"https://openalex.org/F4320336046","display_name":"NIHR School for Primary Care Research","ror":"https://ror.org/03wz10q85"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3000659570.pdf","grobid_xml":"https://content.openalex.org/works/W3000659570.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1247968195","https://openalex.org/W1481796766","https://openalex.org/W1988301094","https://openalex.org/W1997115741","https://openalex.org/W2002751834","https://openalex.org/W2020982355","https://openalex.org/W2093049395","https://openalex.org/W2098923148","https://openalex.org/W2110438413","https://openalex.org/W2113572448","https://openalex.org/W2114874476","https://openalex.org/W2141091656","https://openalex.org/W2154317807","https://openalex.org/W2163710303","https://openalex.org/W2294274888","https://openalex.org/W2300498424","https://openalex.org/W2339850880","https://openalex.org/W2401750321","https://openalex.org/W2432501512","https://openalex.org/W2523042213","https://openalex.org/W2551793627","https://openalex.org/W2588681363","https://openalex.org/W2772803673","https://openalex.org/W2788942218"],"related_works":["https://openalex.org/W4388281240","https://openalex.org/W4292631694","https://openalex.org/W3097791785","https://openalex.org/W4404485287","https://openalex.org/W2020370186","https://openalex.org/W2341654874","https://openalex.org/W2050344489","https://openalex.org/W3026380867"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"compare":[2],"the":[3,45,60,65,69,72,178,194,270],"benefits":[4],"and":[5,19,22,28,68,234],"harms":[6],"of":[7,41,62,71,97,107,187,196,237,272,278],"naltrexone-bupropion":[8,121],"using":[9,64,74],"evidence":[10,73],"from":[11,109],"clinical":[12,98],"study":[13,99],"reports.":[14],"METHODS:":[15],"We":[16,51,58,76],"searched":[17],"Food":[18],"Drug":[20],"Administration":[21],"European":[23,46],"Medicines":[24,47],"Agency":[25,48],"websites,":[26],"PubMed,":[27],"Clinicaltrials.gov":[29],"(May":[30],"2016)":[31],"to":[32,44,90,145,148,210,229,251],"identify":[33],"pivotal":[34,111],"trials;":[35],"we":[36,93],"then":[37],"sent":[38],"a":[39,78,85,155,264],"freedom":[40],"information":[42],"request":[43],"(July":[49,88],"2016).":[50],"included":[52],"pivotal,":[53],"phase":[54],"III":[55],"placebo-controlled":[56],"trials.":[57],"assessed":[59],"risks":[61],"bias":[63],"Cochrane":[66],"criteria,":[67],"quality":[70],"GRADE.":[75],"used":[77],"random-effects":[79],"model":[80],"for":[81,182],"meta-analyses.":[82],"RESULTS:":[83],"Over":[84],"27-month":[86],"period":[87],"2016":[89],"August":[91],"2018),":[92],"received":[94],"31":[95],"batches":[96],"report":[100],"documents":[101],"containing":[102],"over":[103],"65":[104],"000":[105],"pages":[106],"data":[108],"4":[110],"trials":[112],"(n":[113],"=":[114,131,138,141,150,200,204,207,212,219,226,231,241,248,254],"4536).":[115],"Significantly":[116],"more":[117],"participants":[118],"who":[119],"took":[120],"achieved":[122],"\u22655%":[123],"reduction":[124,159],"in":[125,160],"body":[126,162,261],"weight:":[127],"risk":[128,175,195,271],"ratio":[129],"(RR)":[130],"2.1":[132],"(95%":[133],"confidence":[134],"interval":[135],"1.35-3.28),":[136],"P":[137,203,222,244],".001,":[139],"GRADE":[140,206,225,247],"low,":[142,208],"number":[143],"needed":[144],"treat":[146],"(NNT)":[147],"benefit":[149],"5":[151],"(3-17);":[152],"this":[153],"represents":[154],"2.53":[156],"kg":[157],"(1.85-3.21)":[158],"baseline":[161],"weight":[163,262],"compared":[164],"with":[165],"placebo.":[166],"Naltrexone-bupropion":[167,191,258],"had":[168],"significantly":[169,192,259,268],"beneficial":[170],"effects":[171],"on":[172],"other":[173],"cardiovascular":[174],"factors;":[176],"however,":[177],"true":[179],"effect":[180],"sizes":[181],"these":[183],"are":[184],"uncertain":[185],"because":[186,236],"incomplete":[188],"outcome":[189],"data.":[190],"increased":[193],"adverse":[197,216,238,273],"events:":[198,217,239],"RR":[199,218,240],"1.11":[201],"(1.05-1.18,":[202],".0004,":[205],"NNT":[209,228,250],"harm":[211,230],"12":[213],"7-27);":[214],"serious":[215],"1.70":[220],"(1.38-2.1,":[221],"<":[223,245],".00001,":[224,246],"moderate,":[227,249],"21":[232],"13-38);":[233],"discontinuation":[235],"1.92":[242],"(1.65-2.24,":[243],"discontinue":[252],"treatment":[253],"9":[255],"8-13).":[256],"CONCLUSIONS:":[257],"reduces":[260],"by":[263],"small":[265],"amount":[266],"but":[267],"increases":[269],"events.":[274],"A":[275],"rigorous":[276],"process":[277],"postmarketing":[279],"surveillance":[280],"is":[281],"required.":[282]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3000659570","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":28},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-01-23T00:00:00"}
